Jamieson Wellness Inc. (TSE:JWEL) Senior Officer Sells C$224,847.00 in Stock

Jamieson Wellness Inc. (TSE:JWEL) Senior Officer Regan Stewart sold 6,300 shares of Jamieson Wellness stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of C$35.69, for a total value of C$224,847.00.

Regan Stewart also recently made the following trade(s):

• On Friday, November 15th, Regan Stewart sold 1,637 shares of Jamieson Wellness stock. The shares were sold at an average price of C$35.67, for a total transaction of C$58,384.75.
• On Monday, August 26th, Regan Stewart sold 8,732 shares of Jamieson Wellness stock. The shares were sold at an average price of C$31.65, for a total value of C$276,373.04.

Jamieson Wellness Stock Performance

JWEL opened at C$36.60 on Tuesday. Jamieson Wellness Inc. has a 12-month low of C$23.98 and a 12-month high of C$36.98. The firm has a market capitalization of C$1.52 billion, a P/E ratio of 42.56 and a beta of 0.63. The stock’s 50 day moving average price is C$34.73 and its two-hundred day moving average price is C$31.32. The company has a quick ratio of 1.08, a current ratio of 3.21 and a debt-to-equity ratio of 92.76.

Jamieson Wellness Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Friday, December 13th will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Friday, November 29th. This represents a $0.84 dividend on an annualized basis and a yield of 2.30%. This is a positive change from Jamieson Wellness’s previous quarterly dividend of $0.19. Jamieson Wellness’s payout ratio is 97.67%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on JWEL. National Bankshares lifted their price objective on shares of Jamieson Wellness from C$36.50 to C$42.00 in a research note on Monday. Canaccord Genuity Group upped their price target on Jamieson Wellness from C$32.50 to C$36.25 in a research note on Friday, August 9th. TD Securities raised their price objective on Jamieson Wellness from C$40.00 to C$42.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Royal Bank of Canada upped their target price on Jamieson Wellness from C$37.00 to C$38.00 in a research report on Friday, November 8th. Finally, BMO Capital Markets lifted their price target on shares of Jamieson Wellness from C$35.00 to C$42.00 in a research report on Friday, August 9th.

Jamieson Wellness Company Profile

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.